FIVE-YEAR DENOSUMAB TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST TWO YEARS OF THE FREEDOM TRIAL EXTENSION

被引：0

作者：

Papapoulos, S. ^{[1
]}

Man, Z. ^{[9
]}

Mellstrom, D. ^{[10
]}

Radominski, S. ^{[11
]}

Reginster, J-Y ^{[12
]}

Resch, H. ^{[13
]}

Roman, J. ^{[14
]}

Roux, C. ^{[15
]}

Cummings, S. ^{[16
]}

Bone, H. ^{[17
]}

Chapurlat, R. ^{[2
]}

Brandi, M. ^{[3
]}

Brown, J. ^{[4
,5
]}

Czerwinski, E. ^{[6
]}

Daizadeh, N. ^{[7
]}

Grauer, A. ^{[7
]}

Krieg, M-A ^{[8
]}

Libanati, C. ^{[7
]}

机构：

[1] Leiden Univ, Med Ctr, Leiden, Netherlands

[2] Hop Edouard Herriot, Lyon, France

[3] Univ Florence, Azienda Osped Careggi, Florence, Italy

[4] Univ Laval, Quebec City, PQ, Canada

[5] CHUQ, Quebec City, PQ, Canada

[6] Krakow Med Ctr, Krakow, Poland

[7] Amgen Inc, Thousand Oaks, CA USA

[8] CHU Vaudois, CHUV, Lausanne, Switzerland

[9] Ctr TIEMPO, Buenos Aires, DF, Argentina

[10] Sahlgrens Acad, Ctr Bone Res, Gothenburg, Sweden

[11] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil

[12] Univ Liege, Liege, Belgium

[13] Krankenhaus Barmherzigen Schwestern II, Med Abt, Vienna, Austria

[14] Hosp Dr Peset, Valencia, Spain

[15] Hop Cochin CEMO, Paris, France

[16] San Francisco Coordinating Ctr, CPMC Res Inst, San Francisco, CA USA

[17] Michigan Bone & Mineral Clin, Detroit, MI USA

来源：

OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：107 / 108

页数：2

共 50 条

[21] The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
Papapoulos, S.
Lippuner, K.
Roux, C.
Lin, C. J. F.
Kendler, D. L.
Lewiecki, E. M.
Brandi, M. L.
Czerwinski, E.
Franek, E.
Lakatos, P.
Mautalen, C.
Minisola, S.
Reginster, J. Y.
Jensen, S.
Daizadeh, N. S.
Wang, A.
Gavin, M.
Libanati, C.
Wagman, R. B.
Bone, H. G.
OSTEOPOROSIS INTERNATIONAL, 2015, 26 (12) : 2773 - 2783
[22] The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
S. Papapoulos
K. Lippuner
C. Roux
C. J. F. Lin
D. L. Kendler
E. M. Lewiecki
M. L. Brandi
E. Czerwiński
E. Franek
P. Lakatos
C. Mautalen
S. Minisola
J. Y. Reginster
S. Jensen
N. S. Daizadeh
A. Wang
M. Gavin
C. Libanati
R. B. Wagman
H. G. Bone
Osteoporosis International, 2015, 26 : 2773 - 2783
[23] Effect of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Eight-Year Results from the Freedom Extension, Phase 3 Clinical Trial
Lewiecki, E. Michael
Papapoulos, Socrates
Lippuner, Kurt
Roux, Christian
Lin, Celia J. F.
Kendler, David L.
Brandi, Maria L.
Czerwinski, Edward
Franek, Edward
Lakatos, Peter
Minisola, Salvatore
Reginster, Jean-Yves
Jensen, Soren
Daizadeh, Nadia
Wang, Andrea
Gavin, Mary
Wagman, Rachel B.
Bone, Henry G.
ENDOCRINE REVIEWS, 2014, 35 (03)
[24] The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
Bone, Henry G.
Chapurlat, Roland
Brandi, Maria-Luisa
Brown, Jacques P.
Czerwinski, Edward
Krieg, Marc-Antoine
Mellstrom, Dan
Radominski, Sebastiao C.
Reginster, Jean-Yves
Resch, Heinrich
Roman Ivorra, Jose A.
Roux, Christian
Vittinghoff, Eric
Daizadeh, Nadia S.
Wang, Andrea
Bradley, Michelle N.
Franchimont, Nathalie
Geller, Michelle L.
Wagman, Rachel B.
Cummings, Steven R.
Papapoulos, Socrates
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (11): : 4483 - 4492
[25] 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
Bone, Henry G.
Wagman, Rachel B.
Brandi, Maria L.
Brown, Jacques P.
Chapurlat, Roland
Cummings, Steven R.
Czerwinski, Edward
Fahrleitner-Pammer, Astrid
Kendler, David L.
Lippuner, Kurt
Reginster, Jean-Yves
Roux, Christian
Malouf, Jorge
Bradley, Michelle N.
Daizadeh, Nadia S.
Wang, Andrea
Dakin, Paula
Pannacciulli, Nicola
Dempster, David W.
Papapoulos, Socrates
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07): : 513 - 523
[26] Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing Results from the FREEDOM Trial
Adami, Silvano
Libanati, Cesar
Boonen, Steven
Cummings, Steven R.
Ho, Pei-Ran
Wang, Andrea
Siris, Ethel
Lane, Joseph
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2012, 94A (23): : 2113 - 2119
[27] Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension
Ferrari, Serge
Eastell, Richard
Napoli, Nicola
Schwartz, Ann
Hofbauer, Lorenz C.
Chines, Arkadi
Wang, Andrea
Pannacciulli, Nico
Cummings, Steven R.
BONE, 2020, 134
[28] Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
Leder, Benjamin Z.
Tsai, Joy N.
Uihlein, Alexander V.
Burnett-Bowie, Sherri-Ann M.
Zhu, Yuli
Foley, Katelyn
Lee, Hang
Neer, Robert M.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05): : 1694 - 1700
[29] Lasofoxifene and Cardiovascular Events in Postmenopausal Women With Osteoporosis Five-Year Results From the Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) Trial
Ensrud, Kristine
LaCroix, Andrea
Thompson, John R.
Thompson, David D.
Eastell, Richard
Reid, David M.
Vukicevic, Slobodan
Cauley, Jane
Barrett-Connor, Elizabeth
Armstrong, Roisin
Welty, Francine
Cummings, Steven
CIRCULATION, 2010, 122 (17) : 1716 - +
[30] FREEDOM TRIAL: DENOSUMAB IS NOT ASSOCIATED WITH FRACTURE HEALING COMPLICATIONS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Adami, Silvano
Palacios, Santiago
Pavelka, Karel
Resch, Heinrich
Roux, Christian
Uebelhart, Daniel
Ho, Pei-Ran
Wang, Andrea
Siris, Ethel
Libanati, Cesar
Adachi, Jonathan
Boonen, Steven
Cummings, Steven
de Gregorio, Luiz
Gilchrist, Nigel
Lyritis, George
Moeller, Gerd
OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 243 - 244

← 1 2 3 4 5 →